This recommendation contributed to the Scottish Government’s decision to invest £14.6 million in 2021/2022 to improve patient access to a range of diabetes technologies, monies that were subsequently allocated to Boards to support rapid deployment. To take forward the recommendation established by the Scottish Health Technologies Group, NHS Tayside currentl...